These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 24767205

  • 21. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
    Suares NC, Hamlin PJ, Greer DP, Warren L, Clark T, Ford AC.
    Aliment Pharmacol Ther; 2012 Jan; 35(2):284-91. PubMed ID: 22112005
    [Abstract] [Full Text] [Related]

  • 22. Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studies.
    Hausmann J, Zabel K, Herrmann E, Schröder O.
    Inflamm Bowel Dis; 2010 Jul; 16(7):1195-202. PubMed ID: 19924799
    [Abstract] [Full Text] [Related]

  • 23. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
    Myrelid P, Svärm S, Andersson P, Almer S, Bodemar G, Olaison G.
    Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204
    [Abstract] [Full Text] [Related]

  • 24. Immunomodulation with methotrexate: underused and undervalued?
    Ruemmele FM.
    Dig Dis; 2009 Oct; 27(3):312-4. PubMed ID: 19786757
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of parenteral methotrexate in refractory Crohn's disease.
    Chong RY, Hanauer SB, Cohen RD.
    Aliment Pharmacol Ther; 2001 Jan; 15(1):35-44. PubMed ID: 11136276
    [Abstract] [Full Text] [Related]

  • 26. 6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease.
    Maté-Jiménez J, Hermida C, Cantero-Perona J, Moreno-Otero R.
    Eur J Gastroenterol Hepatol; 2000 Nov; 12(11):1227-33. PubMed ID: 11111780
    [Abstract] [Full Text] [Related]

  • 27. American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
    Dassopoulos T, Sultan S, Falck-Ytter YT, Inadomi JM, Hanauer SB.
    Gastroenterology; 2013 Dec; 145(6):1464-78.e1-5. PubMed ID: 24267475
    [No Abstract] [Full Text] [Related]

  • 28. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S, Noble A, Deslandres C.
    Inflamm Bowel Dis; 2011 Dec; 17(12):2521-6. PubMed ID: 21337668
    [Abstract] [Full Text] [Related]

  • 29. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
    Klimczak K, Łykowska-Szuber L, Krela-Kaźmierczak I, Eder P, Szymczak A, Stawczyk-Eder K, Linke K.
    Wiad Lek; 2016 Dec; 69(2 Pt 2):262-6. PubMed ID: 27487545
    [Abstract] [Full Text] [Related]

  • 30. Sustained clinical benefit and tolerability of methotrexate monotherapy after thiopurine therapy in patients with Crohn's disease.
    Seinen ML, Ponsioen CY, de Boer NK, Oldenburg B, Bouma G, Mulder CJ, van Bodegraven AA.
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):667-72. PubMed ID: 23333660
    [Abstract] [Full Text] [Related]

  • 31. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease.
    Rosh JR, Lerer T, Markowitz J, Goli SR, Mamula P, Noe JD, Pfefferkorn MD, Kelleher KT, Griffiths AM, Kugathasan S, Keljo D, Oliva-Hemker M, Crandall W, Carvalho RS, Mack DR, Hyams JS.
    Am J Gastroenterol; 2009 Dec; 104(12):3042-9. PubMed ID: 19724267
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Use of methotrexate in patients with inflammatory bowel diseases.
    Preiss JC, Zeitz M.
    Clin Exp Rheumatol; 2010 Dec; 28(5 Suppl 61):S151-5. PubMed ID: 21044450
    [Abstract] [Full Text] [Related]

  • 38. [Azathioprine in inflammatory bowel disease].
    Leite S, Ribeiro JM, Lima SC, Barroso S, Cotter J.
    Acta Med Port; 2009 Dec; 22(1):33-40. PubMed ID: 19341591
    [Abstract] [Full Text] [Related]

  • 39. The safety and tolerability of methotrexate for treating patients with Crohn's disease.
    Chande N, Abdelgadir I, Gregor J.
    J Clin Gastroenterol; 2011 Aug; 45(7):599-601. PubMed ID: 21224737
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.